GSVTX
Price
$16.70
Change
-$0.03 (-0.18%)
Updated
Sep 3 closing price
Net Assets
435.6M
RMFCX
Price
$60.11
Change
-$0.10 (-0.17%)
Updated
Sep 3 closing price
Net Assets
109.45B
Interact to see
Advertisement

GSVTX vs RMFCX

Header iconGSVTX vs RMFCX Comparison
Open Charts GSVTX vs RMFCXBanner chart's image
Goldman Sachs Large Cap Value I
Price$16.70
Change-$0.03 (-0.18%)
VolumeN/A
Net Assets435.6M
American Funds American Mutual R3
Price$60.11
Change-$0.10 (-0.17%)
VolumeN/A
Net Assets109.45B
GSVTX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSVTX vs. RMFCX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVTX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 109B vs. GSVTX (436M). RMFCX (1.24) and GSVTX (1.23) have matching dividends . GSVTX was incepted earlier than RMFCX: GSVTX (18 years) vs RMFCX (23 years). GSVTX (1.00) is less costly to investors than RMFCX (0.91). GSVTX is a more actively managed with annual turnover of: 51.00 vs. RMFCX (31.00). GSVTX has a lower initial minimum investment than RMFCX: GSVTX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 6.48 vs. GSVTX (-2.61). RMFCX return over 5 years is better than : 55.53 vs. GSVTX (26.80).
GSVTXRMFCXGSVTX / RMFCX
Total Expense Ratio0.750.9182%
Annual Report Gross Expense Ratio1.000.91110%
Fund Existence18 years23 years-
Gain YTD6.02010.79556%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets436M109B0%
Annual Yield % from dividends1.231.2499%
Returns for 1 year-2.616.48-40%
Returns for 3 years16.1730.9852%
Returns for 5 years26.8055.5348%
Returns for 10 years18.2594.4319%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.120.04
+1.92%
CytomX Therapeutics
WINA463.167.15
+1.57%
Winmark Corp
LGCL0.51N/A
-0.60%
Lucas GC Limited
GRFS9.59-0.09
-0.93%
Grifols SA
ALDFU10.50-0.50
-4.55%
Aldel Financial II Inc